No Picture
News

Viridian Therapeutics Announces Proposed Underwritten Public Offering of Common Stock and Preferred Stock

WALTHAM, Mass., Sept. 20, 2021 (GLOBE NEWSWIRE) — Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company advancing new treatments for patients suffering from serious diseases but underserved by today’s therapies, today announced that it has commenced an underwritten public offering of shares of its common stock and series B… Click here to view original post… […]

No Picture
News

Immuneering Announces Inclusion in the Russell 2000® Index

CAMBRIDGE, Mass., Sept. 20, 2021 (GLOBE NEWSWIRE) — Immuneering Corporation (Nasdaq: IMRX), a biopharmaceutical company advancing a robust pipeline of oncology and neuroscience product candidates that are designed to uniquely disrupt cellular signaling dynamics, today announced that Immuneering Corporation has been selected to be added to the Russell 2000® Index… Click here to view original post… […]